In
recent
years
,
incidence
Human
Papilloma
Virus
(
HPV
)
-positive
head
neck
squamous
cell
carcinomas
(
HNSCC
)
markedly
increased
.

Our
aim
design
novel
therapeutic
agent
use
conditionally
replicative
adenoviruses
(
CRAds
)
targeted
HPV
E6
E7
oncoproteins
.

